文献速递血管炎其他结缔组织病

嗜酸性肉芽肿性多血管炎中嗜酸性粒细胞ETosis释放半乳糖凝集素-10

Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.
PubMed 文献 · Arthritis Rheumatol · 2021-08-11

该研究探讨嗜酸性肉芽肿性多血管炎(EGPA)中嗜酸性粒细胞ETosis的特征。体外实验显示ETosis依赖活性氧和PAD4介导的组蛋白瓜氨酸化,导致嗜酸性粒细胞胞外诱捕网、游离半乳糖凝集素-10及膜结合完整颗粒的胞解性释放。EGPA患者组织浸润嗜酸性粒细胞可见EETosis特征,血清半乳糖凝集素-10水平与疾病活动度正相关。

要点

  • EGPA组织浸润嗜酸性粒细胞发生EETosis,表现为胞质半乳糖凝集素-10丢失和颗粒沉积。
  • 血清半乳糖凝集素-10与BVAS评分正相关(r=0.8531,P<0.0001),经血嗜酸性粒细胞计数归一化后仍相关(r=0.7168,P<0.0001)。
  • 活动期EGPA血清半乳糖凝集素-10水平与血清IL-5正相关。

核心结论

  • EGPA患者病变组织浸润的嗜酸性粒细胞发生EETosis,血清半乳糖凝集素-10升高可能反映系统性胞解性EETosis。

研究设计与样本

  • 体外研究使用血源性嗜酸性粒细胞表征EETosis,并通过免疫染色和电镜观察EGPA患者组织中的EETosis。
  • 检测健康对照、哮喘患者及活动期或缓解期EGPA患者(每组n=15)的血清嗜酸性粒细胞衍生蛋白浓度。

主要发现

  • EETosis依赖活性氧和PAD4依赖性组蛋白瓜氨酸化,导致网状嗜酸性粒细胞胞外诱捕网、游离半乳糖凝集素-10和膜结合完整颗粒的胞解性释放。
  • EGPA患者多种组织浸润嗜酸性粒细胞中观察到EETosis特征,包括胞质半乳糖凝集素-10丢失和颗粒沉积。
  • EGPA患者血清嗜酸性粒细胞颗粒蛋白和半乳糖凝集素-10水平升高,且与BVAS评估的疾病活动度正相关(半乳糖凝集素-10:r=0.8531,P<0.0001)。
  • 经血嗜酸性粒细胞计数归一化后,半乳糖凝集素-10与疾病活动度的相关性仍存在(r=0.7168,P<0.0001),而颗粒蛋白则不然。
  • 活动期EGPA患者半乳糖凝集素-10水平与血清IL-5水平正相关。

临床怎么用

  • 血清半乳糖凝集素-10可能作为反映EGPA疾病活动度的生物标志物,尤其在与血嗜酸性粒细胞计数联合评估时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Eosinophils are tissue-dwelling immune cells. Accumulating evidence indicates that a type of cell death termed ETosis is an important cell fate involved in the pathophysiology of inflammatory diseases. Although the critical role of eosinophils in eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) is well established, the presence of eosinophil ETosis (EETosis) is poorly understood. We undertook this study to better understand the characteristics of EETosis. METHODS: In vitro studies using blood-derived eosinophils were conducted to characterize EETosis. The occurrence of EETosis in tissues from patients with EGPA was studied by immunostaining and electron microscopy. Serum concentrations of eosinophil-derived proteins in healthy controls, patients with asthma, and EGPA patients with active disease or with disease in remission (n = 15 per group) were examined. RESULTS: EETosis was reliant on reactive oxygen species and peptidylarginine deiminase type 4-dependent histone citrullination, resulting in the cytolytic release of net-like eosinophil extracellular traps, free galectin-10, and membrane-bound intact granules. The signature of EETosis, including loss of cytoplasmic galectin-10 and deposition of granules, was observed in eosinophils infiltrating various tissues from EGPA patients. Serum eosinophil granule proteins and galectin-10 levels were increased in EGPA and positively correlated with disease activity as assessed by the Birmingham Vasculitis Activity Score (r = 0.8531, P < 0.0001 for galectin-10). When normalized to blood eosinophil counts, this correlation remained for galectin-10 (r = 0.7168, P < 0.0001) but not for granule proteins. Galectin-10 levels in active EGPA positively correlated with serum interleukin-5 levels. CONCLUSION: Eosinophils infiltrating diseased tissues in EGPA undergo EETosis. Considering the exclusive expression and large pool of cytoplasmic galectin-10 in eosinophils, elevated serum galectin-10 levels in patients with EGPA might reflect the systemic occurrence of cytolytic EETosis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fukuchi M, Kamide Y, Ueki S, et al. Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2021. PMID: 33750029. doi:10.1002/art.41727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。